TY - JOUR
T1 - Applying 'omics technologies in chemicals risk assessment
T2 - Report of an ECETOC workshop
AU - Buesen, Roland
AU - Chorley, Brian N
AU - da Silva Lima, Beatriz
AU - Daston, George P.
AU - Deferme, Lize
AU - Ebbels, Timothy
AU - Gant, Timothy W
AU - Goetz, Amber
AU - Greally, John
AU - Gribaldo, Laura
AU - Hackermüller, Jörg
AU - Hubesch, Bruno
AU - Jennen, Danyel G J
AU - Johnson, Kamin
AU - Kanno, Jun
AU - Kauffmann, Hans-Martin
AU - Laffont, Madeleine
AU - McMullen, Patrick
AU - Meehan, Richard
AU - Pemberton, Mark
AU - Perdichizzi, Stefania
AU - Piersma, Aldert H
AU - Sauer, Ursula G
AU - Schmidt, Kerstin
AU - Seitz, Hervé
AU - Sumida, Kayo
AU - Tollefsen, Knut Erik
AU - Tong, Weida
AU - Tralau, Tewes
AU - van Ravenzwaay, Ben
AU - Weber, Ralf J M
AU - Worth, Andrew
AU - Yauk, Carole
AU - Poole, Alan
N1 - Crown Copyright © 2017. Published by Elsevier Inc. All rights reserved.
PY - 2017/12
Y1 - 2017/12
N2 - Prevailing knowledge gaps in linking specific molecular changes to apical outcomes and methodological uncertainties in the generation, storage, processing, and interpretation of 'omics data limit the application of 'omics technologies in regulatory toxicology. Against this background, the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) convened a workshop Applying 'omics technologies in chemicals risk assessment that is reported herein. Ahead of the workshop, multi-expert teams drafted frameworks on best practices for (i) a Good-Laboratory Practice-like context for collecting, storing and curating 'omics data; (ii) the processing of 'omics data; and (iii) weight-of-evidence approaches for integrating 'omics data. The workshop participants confirmed the relevance of these Frameworks to facilitate the regulatory applicability and use of 'omics data, and the workshop discussions provided input for their further elaboration. Additionally, the key objective (iv) to establish approaches to connect 'omics perturbations to phenotypic alterations was addressed. Generally, it was considered promising to strive to link gene expression changes and pathway perturbations to the phenotype by mapping them to specific adverse outcome pathways. While further work is necessary before gene expression changes can be used to establish safe levels of substance exposure, the ECETOC workshop provided important incentives towards achieving this goal.
AB - Prevailing knowledge gaps in linking specific molecular changes to apical outcomes and methodological uncertainties in the generation, storage, processing, and interpretation of 'omics data limit the application of 'omics technologies in regulatory toxicology. Against this background, the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) convened a workshop Applying 'omics technologies in chemicals risk assessment that is reported herein. Ahead of the workshop, multi-expert teams drafted frameworks on best practices for (i) a Good-Laboratory Practice-like context for collecting, storing and curating 'omics data; (ii) the processing of 'omics data; and (iii) weight-of-evidence approaches for integrating 'omics data. The workshop participants confirmed the relevance of these Frameworks to facilitate the regulatory applicability and use of 'omics data, and the workshop discussions provided input for their further elaboration. Additionally, the key objective (iv) to establish approaches to connect 'omics perturbations to phenotypic alterations was addressed. Generally, it was considered promising to strive to link gene expression changes and pathway perturbations to the phenotype by mapping them to specific adverse outcome pathways. While further work is necessary before gene expression changes can be used to establish safe levels of substance exposure, the ECETOC workshop provided important incentives towards achieving this goal.
KW - Regulatory toxicology
KW - Transcriptomics
KW - Metabolomics
KW - Good laboratory practice (GLP)
KW - Weight-of-evidence (WoE)
KW - Adverse outcome pathway (AOP)
KW - Mode-of-action (MoA)
KW - Gene expression
KW - Differentially expressed genes
U2 - 10.1016/j.yrtph.2017.09.002
DO - 10.1016/j.yrtph.2017.09.002
M3 - Article
C2 - 28958911
SN - 0273-2300
VL - 91
SP - S3-S13
JO - Regulatory Toxicology and Pharmacology
JF - Regulatory Toxicology and Pharmacology
IS - Suppl 1
ER -